Vnitr Lek 2010, 56(9):927-931

Hereditary angioedema - neglected diagnosis

P. Králíčková1,*, E. Burešová1, T. Freiberger2, I. Tachecí3
1 Ústav klinické imunologie a alergologie Lékařské fakulty UK a FN Hradec Králové, přednosta prof. RNDr. Jan Krejsek, CSc.
2 Genetická laboratoř Centra kardiovaskulární a transplantační chirurgie Brno, ředitel doc. MUDr. Petr Němec, CSc., FETCS
3 Oddělení gastroenterologie a hepatologie, vedoucí prof. MUDr. Jan Bureš, CSc., II. interní kliniky Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jaroslav Malý, CSc.

Hereditary angioedema caused by C1 esterase inhibitor deficiency is a rare autosomal dominant inherited disorder. It is characterized by reccurent episodes of potentially life-threatening swellings without itching localized in the dermis and submucosa. We report a case of 41 years old woman with hereditary angioedema manifested as episodes of localized skin swellings and painful gastrointestinal colics. This report underlines the fact that hereditary angioedema is underdiagnosed in differential diagnoses. If hereditary angioedema is correctly diagnosed, effective treatment highly improving patients' quality of life is available.

Keywords: angioedema; C1 inhibitor; danazol

Received: March 19, 2010; Accepted: April 20, 2010; Published: September 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Králíčková P, Burešová E, Freiberger T, Tachecí I. Hereditary angioedema - neglected diagnosis. Vnitr Lek. 2010;56(9):927-931.
Download citation

References

  1. Gompels MM, Lock RJ, Abinum M et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005; 139: 379-394. Go to original source... Go to PubMed...
  2. Kuklínek P. Hereditární a získaný angioedém (deficit C1-INH). In: Špičák V, Panzner P (eds). Alergologie. Praha: Galén 2004: 257-262.
  3. Cugno M, Zanichelli A, Foieni F et al. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 2009; 15: 69-78. Go to original source... Go to PubMed...
  4. Krejsek J, Kopecký O. Klinická imunologie. Hradec Králové: Nucleus 2004: 81-196.
  5. Temiňo VM, Peebles RS Jr. The spectrum and treatment of angioedema. Am J Med 2008; 121: 282-286. Go to original source... Go to PubMed...
  6. Cichon S, Martin L, Hennies HC et al. Increased activity of coagulation factor XII (Hageman factor) cause hereditary angioedema type III. Am J Hum Genet 2006; 79: 1098-1104. Go to original source... Go to PubMed...
  7. Rosen FS, Davis AE 3rd. Deficiencies of C1 inhibitor. Best Pract Res Clin Gastroenterol 2005; 19: 251-261. Go to original source... Go to PubMed...
  8. Bork K, Meng G, Staubach P et al. Hereditary angioedema: New findings concerning symptoms, affected organs, and course. Am J Med 2006; 119: 267-274. Go to original source... Go to PubMed...
  9. Craig T, Riedl M, Dykewicz MS et al. When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol 2009; 102: 366-72. Go to original source... Go to PubMed...
  10. Cicardi M, Zingale L. How do we treat patients with hereditary angioedema. Transfus Apher Sci 2003; 29: 221-227. Go to original source... Go to PubMed...
  11. Bowen T, Herbert J, Ritchie B et al. Management of hereditary angioedema: a Canadian approach. Transfus Apher Sci 2003; 29: 205-214. Go to original source... Go to PubMed...
  12. Craig TJ, Levy RJ, Wasserman RL et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 2009; 124: 801-808. Go to original source... Go to PubMed...
  13. Christiansen SC, Zuraw BL. Update on therapeutic developments for hereditary angioedema. Allergy Asthma Proc 2009; 30: 500-505. Go to original source... Go to PubMed...
  14. De Serres J, Gröner A, Lindner J. Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinet P) in hereditary angioedema: a review. Transfus Apher Sci 2003; 29: 247-254. Go to original source... Go to PubMed...
  15. Fincham CI, Bressan A, Paris M et al. Bradykinin receptor antagonista - a review of the patent literature 2005-2008. Expert Opin Ther Pat 2009; 19: 919-941. Go to original source... Go to PubMed...
  16. Roche O, Blanch A, Duponchel C et al. Hereditary angioedema: The mutation spectrum of SERPING1/C1NH in a large Spanish cohort. Hum Mutat 2005; 26: 135-144. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.